1. Immediate referral to colposcopy versus cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature
- Author
-
Marc Arbyn, Ilkka Kalliala, Christina Fotopoulou, Pierre Martin-Hirsch, Ka Ying Bonnie Ng, Evangelos Paraskevaidis, Anita Mitra, Maria Kyrgiou, and Olivia Raglan
- Subjects
Gynecology ,Colposcopy ,Cancer Research ,medicine.medical_specialty ,medicine.diagnostic_test ,Obstetrics ,business.industry ,Dyskaryosis ,medicine.disease ,Cervical intraepithelial neoplasia ,Koilocyte ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Relative risk ,Meta-analysis ,medicine ,030212 general & internal medicine ,business ,Ascus ,Cervix - Abstract
We performed a systematic review and meta-analysis to explore the optimum management strategy for women with atypical squamous cells of undetermined significance (ASCUS/borderline) or low-grade squamous intra-epithelial lesions (LSIL/mild dyskaryosis) cytological abnormalities at primary screening in the absence of HPV DNA test. We searched MEDLINE, EMBASE and CENTRAL and included randomised controlled trials comparing immediate colposcopy to cytological surveillance in women with ASCUS/LSIL. The outcomes of interest were occurrence of different histological grades of cervical intraepithelial neoplasia (CIN) and default rates during follow-up. Pooled risk ratios (RR) and 95% confidence intervals (CI) were calculated using a random-effect model and with inverse variance weighting. Interstudy heterogeneity was assessed using I2 statistics. Six RCTs were included. Immediate colposcopy significantly increased detection of unimportant abnormalities as opposed to repeat cytology (koilocytosis: 32 vs. 21%, RR: 1.49, 95% CI = 1.17–1.90); CIN1: 21 vs. 8%, RR: 2.58, 95% CI = 1.69–3.94). Although immediate colposcopy detected CIN2, CIN2+, and CIN3+ earlier than cytology, the differences were no longer observed at 24 months (CIN3+: 10.3 vs.11.9%, RR: 1.02, 95% CI = 0.53–1.97), with significant interstudy heterogeneity (p
- Published
- 2016
- Full Text
- View/download PDF